CLINICAL_TRIALS
trial_result
· 2012-01-24
Clinical Trial Update: A Study of LY2624587 in Patients With Advanced Cancer [Phase 1]
Summary
Phase 1 study update for LY2624587 in patients with metastatic cancer; the trial has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Metastatic Cancer | Phase 1 | Status: COMPLETED